FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/01/039622 [Registered on: 21/01/2022] Trial Registered Prospectively
Last Modified On: 09/02/2022
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Retrospective Observational study 
Study Design  Other 
Public Title of Study   Anesthesia management of covid-19 associated ROC mucormycosis 
Scientific Title of Study   Perioperative anesthetic management of covid-19 associated rhinoorbitocerebral mucormycosis 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Ashwini Yadavrao Sontakke 
Designation  Senior Registrar 
Affiliation  Government Medical College, Nanded 
Address  Department of Anaesthesia, Dr. Shankarrao Chavan Government Medical College and Hospital Vishnupuri Nanded

Nanded
MAHARASHTRA
431601
India 
Phone  8087330897  
Fax    
Email  drsontakkeashwiniy@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Vaishnavi Kulkarni 
Designation  Professor and Head of the department 
Affiliation  Dr. Shankarrao Chavan Government Medical College, Nanded 
Address  Department of Anaesthesia, Dr. Shankarrao Chavan Government Medical College and Hospital Vishnupuri Nanded

Nanded
MAHARASHTRA
431601
India 
Phone  8087330897  
Fax    
Email  anaesthesiascgmcnanded@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Ashwini Yadavrao Sontakke 
Designation  Senior Registrar 
Affiliation  Government Medical College, Nanded 
Address  Department of Anaesthesia, Dr. Shankarrao Chavan Government Medical College and Hospital Vishnupuri Nanded

Nanded
MAHARASHTRA
431601
India 
Phone  8087330897  
Fax    
Email  drsontakkeashwiniy@gmail.com  
 
Source of Monetary or Material Support  
Dr. Shankarrao Chavan Government Medical College Nanded 431605 
 
Primary Sponsor  
Name  Ashwini Yadavrao Sontakke 
Address  Deparment of Anaesthesia Dr. Shankarrao Chavan Government Medical College Nanded 431601 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ashwini Yadavrao Sontakke  Dr. Shankarrao Chavan Government Medical College and Hospital Vishnupuri Nanded  Room no. 87 Department of Anaesthesia, Dr. Shankarrao Chavan Government Medical College and Hospital Vishnupuri Nanded
Nanded
MAHARASHTRA 
8087330897

drsontakkeashwiniy@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee- Human Resources  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: B972||Coronavirus as the cause of diseases classified elsewhere,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  12.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  All patients posted for emergency or elective surgical resection of rhiniorbitocerebral mucormycosis under general anaesthesia 
 
ExclusionCriteria 
Details  Lack of patients consent
coagulopathy 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1.Study the outcome of patients in following parameters
Requirement of inotropic support, ventilator support, ICU stay, total duration of hospitalization, co-morbid condition affecting the outcome
2.Mortality rate and average mortality time 
1.Before Surgery
2.Intraoperative
3.Immediate postoperative
4.Till discharge / Death
5.30 days
 
 
Secondary Outcome  
Outcome  TimePoints 
Early debidement of disease and outcome of patients.
5.co-relation between predisposing factors and outcome of patients
 
till dischage 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="110" 
Phase of Trial   N/A 
Date of First Enrollment (India)   25/01/2022 
Date of Study Completion (India) 09/02/2022 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   After approval from the ethics committee and written informed consent, patients posted for emergency surgical resection of rhinoorbitocerebral mucormycosis under general anaesthesia satisfying inclusion and exclusion criteria for the study will be observed. intaoperative monitoring will include 3 lead electrocardiogram, heart rate, peripheral oxygen saturation, end tidal carbon dioxide concentration, non invasive blood pressure monitoring. patients, that will not have any intaoperative complications will be extubated in operative room before transfer to post-anaesthesia care unit or ward. however, patients undergoing extensive surgical resection, hemodynamic unstability  are transferred to post anaesthesia care unit with endotracheal tube or tracheostomy tube in situ. 

Parameters to be noted :
age
gender
BMI
systemic Illness
duration of Diabetes
COVID-19 status
vaccination
duration between COVID-19 and rhinoorbitocerebral symptoms
clinical staging of mucormycosis
duration between symptoms and surgery
Amphotericin -b days
pre-operative condition of patient
RT-PCR
ASA-PS grade
airway examination
anticoagulation/bedridden
steroids status
RS
CVS
spo2
RBS
Investigations
intra-operative- pulse/NIBP/
intubation
Ax maintenance
surgery performed
anaesthesia duration
surgery duration
complications
post-anaesthesia care unit
ventilatory support/inotropic support
total days of hospitalisation
total number of debridement
discharged/died
30 days outcome
 
Close